🇺🇸 Tetanus Toxoid Reduced Diphtheria Toxoid Acellular Pertussis in United States

Tetanus Toxoid Reduced Diphtheria Toxoid Acellular Pertussis (Tetanus Toxoid Reduced Diphtheria Toxoid Acellular Pertussis) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Tetanus Toxoid Reduced Diphtheria Toxoid Acellular Pertussis in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in United States

Frequently asked questions

Is Tetanus Toxoid Reduced Diphtheria Toxoid Acellular Pertussis approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Tetanus Toxoid Reduced Diphtheria Toxoid Acellular Pertussis in United States?

Sanofi Pasteur, a Sanofi Company is the originator. The local marketing authorisation holder may differ — check the official source linked above.